← Leaderboards
David I Dorsky
University Of Connecticut Sch Of Med/Dnt
$23,472
Attributed
$23,472
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$23,472 · 1
By mechanism
M01$23,472 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Linda S Cauley$5,416,940
- Louise Deborah McCullough$31,869,189
- Stephen K Wikel$2,748,833
- Bijay Mukherji$4,733,481
- Peter James Krause$2,079,888
Others in their field
Top investigators on “Active Immunization”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$466,593,725
- Judith S. Currier · University Of California Los Angeles$322,872,111
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$256,197,143
- Daniel R Kuritzkes · Brigham And Women'S Hospital$217,875,923
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
Research focus
Active ImmunizationClinical ResearchClinical Trial Phase IDisease /Disorder Proneness /RiskHealth Care PersonnelHemagglutininHuman SubjectHuman Therapy EvaluationInfluenza VaccinesInfluenzavirus AOccupational Health /SafetyVaccine DevelopmentVector Vaccine
Grant awards (7)
PHASE I EVALUATION OF RECOMBINANT INFLUENZA VIRUS H5 HEMAGGLUTININ VA$0
M01 · FY2002 · RR
PHASE I EVALUATION OF RECOMBINANT INFLUENZA VIRUS H5 HEMAGGLUTININ VA$4,361
M01 · FY2001 · RR
PHASE I EVALUATION OF RECOMBINANT INFLUENZA VIRUS H5 HEMAGGLUTININ VA$0
M01 · FY2001 · RR
PHASE I EVALUATION OF RECOMBINANT INFLUENZA VIRUS H5 HEMAGGLUTININ VA$0
M01 · FY2001 · RR
PHASE I EVALUATION OF RECOMBINANT INFLUENZA VIRUS H5 HEMAGGLUTININ VA$19,111
M01 · FY2000 · RR
PHASE I EVALUATION OF RECOMBINANT INFLUENZA VIRUS H5 HEMAGGLUTININ VA$0
M01 · FY2000 · RR
PHASE I EVALUATION OF RECOMBINANT INFLUENZA VIRUS H5 HEMAGGLUTININ VA$0
M01 · FY2000 · RR